Elan (ELN), Novartis (NVS) Tick Higher on PDUFA Extension for Biogen's (BIIB) MS PillBG-12

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. BJ
8. OSIS
9. HD
10. SFNC

Go back to Elan (ELN), Novartis (NVS) Tick Higher on PDUFA Extension for Biogen's (BIIB) MS PillBG-12

Biogen Idec (BIIB) Said FDA Extends PDUFA Date for BG-12 3 Months

October 18, 2012 8:08 AM EDT

Biogen Idec (NASDAQ: BIIB) said the FDA has extended the initial PDUFA date for its review of the New Drug Application (NDA) for the marketing approval of BG-12 (dimethyl fumarate), the companys oral therapeutic candidate for the treatment of multiple sclerosis (MS). The 3... More